The imbalance between the respective thyroid function parameters and FGF21 levels suggests a difference between euthyroid HT on LT4 substitution and healthy subjects regarding the thyroid hormone effects on metabolism, which might contribute to obesity and metabolic changes described among HT patients. The gene discussed is FGF21; the disease is hematocrit.